|Traded as||NYSE: Q|
|Industry||Contract Research Organization
Pharmaceutical Service Consulting
|Headquarters||Durham, North Carolina, USA|
|Key people||Dennis Gillings, Executive Chairman
Tom Pike CEO
John Ratliff President & COO; Paula Brown Stafford, President Clinical
|Products||Support services for pharmaceutical, biotech and medical companies and individuals|
|Revenue||US$ Approximately $3.7 billion|
|Employees||~ 27,000+ (2013)|
Quintiles Transnational is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market.
- 1974: Dennis Gillings signs first contract to provide statistical and data management consulting for pharmaceutical clients.
- 1982: Quintiles, Inc., is incorporated in North Carolina.
- 1990: Quintiles Pacific Inc. and Quintiles Ireland Ltd. established
- 1991: Quintiles GMBH established in Germany; Quintiles Laboratories Ltd. established in Atlanta, Georgia
- 1996: Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO
- 1997: Quintiles goes public, completing successful secondary stock offering.
- 1998: Quintiles is the first company in industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
- 1999: Company joins the S&P 500 Index.
- 2003: Board of Directors agrees to merge with Pharma Services Holdings Inc; Quintiles becomes a private company.
- 2009: Quintiles opens new corporate headquarters in Durham, North Carolina
- 2010: Quintiles opens new European headquarters in the UK and establishes operations in East Africa.
- 2011: Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York
- 2013: Quintiles files for an IPO on 15 February in order to go public again 
- 2013: Quintiles begins trading on the New York Stock Exchange (NYSE) under ticker symbol Q 
- B, Mrs F. "Interview with Quintiles France". Quintiles France. Expatriates Magazine Ed1.
- "Money, Math and Medicine". Forbes Magazine. November 22, 2010. Retrieved April 14, 2011.
- "High-Flying Quintiles to Buy Innovex in $747.5 Million Deal". New York Times. October 8, 1996. Retrieved April 14, 2011.
- Wall Street Journal, May 9, 2013